Company Performance: Profitability, revenue growth, and successful execution of business strategy influence investor confidence.

Industry Trends: The overall health and growth prospects of the pharmaceutical and biotechnology sectors impact investor sentiment.

Market Conditions: Broader economic factors like interest rates, inflation, and overall market sentiment affect investment decisions.

Regulatory Landscape: Changes in regulations governing drug development, approval processes, and pricing can significantly impact valuation.

Competition: The presence and success of competing companies and products can affect market share and profitability.

Clinical Trial Results: Positive or negative data from clinical trials for pipeline drugs directly impacts investor expectations and stock price.

Partnerships and Acquisitions: Strategic alliances, mergers, or acquisitions can alter the company's growth potential and market position.

Investor Sentiment: News, analyst ratings, and general market perception can drive short-term price fluctuations.